FastWave Medical used 2025 to make uncommon progress for an early-stage company, advancing not one but two differentiated IVL platforms — a rare pace in a field where progress often spans years.

Open heart surgery is a common but invasive procedure. Surgeons have tested an unconventional way to perform coronary artery bypass without cracking the chest.

The launch of Coherent AxioView™ strengthens our position in the growing medical photonics market, driven by image-guided ...

For the first time ever in a human, doctors have performed coronary artery bypass grafting without having to cut through the ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

Boston Scientific Corp (NYSE:BSX) said on Thursday it has reached a deal to acquire medical technology firm Penumbra ...

Biomacromolecules are increasingly important for treating major diseases such as tumors, infections, cardiovascular diseases, metabolic disorders, ...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Conavi ...

A new technology has been developed that enables cuffless non-invasive blood pressure monitoring by using ultrasonic to track ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced key milestones achieved in 2025, a year defined by progress, innovation, and growth. Vektor's flagship ...

A new technology has been developed that enables cuffless noninvasive blood pressure monitoring by using ultrasonic to track ...

This year’s Consumer Electronics Show (CES) is offering a glimpse into the future of healthcare. Spanning everything from ...